Skip to main content

Table 2 Adverse events and compliance

From: Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin

Variable, n (%)

Eradication therapy (n = 150)

Fatigue

18 (12.0)

Anorexia

15 (10.0)

Abdominal pain/discomfort

14 (9.3)

Nausea

12 (8.0)

Diarrhea

12 (8.0)

Headache

5 (3.3)

Vomiting

3 (2.0)

Skin rash

2 (1.3)

Taste distortion

2 (1.3)

Dizziness

2 (1.3)

Patients with adverse reactions

32 (21.3)

Mild adverse reactions

20 (13.3)

Moderate adverse reactions

9 (6.0)

Severe adverse reactions (Medication discontinuation)

3 (2.0)

Good compliance

143 (95.3)

  1. Among the enrolled patients, two (one each for lost to follow-up and protocol violation) were not included in adverse effect and compliance assessments